The effectiveness of early colchicine administration in patients over 60 years old with high risk of developing severe pulmonary complications associated with coronavirus pneumonia SARS-CoV-2 (COVID-19): study protocol for an investigator-driven randomized controlled clinical trial in primary health care-COLCHICOVID study.

Autor: Estebanez EB; Management of primary health care centers, Area I, Area II, Area III and Area IV, Servicio Cantabro de Salud, C. Vargas 57, 39010, Santander, Cantabria, Spain., Alconero LL; Marqués de Valdecilla Research Institute (IDIVAL), s/n, Calle Cardenal Herrera Oria, 39012, Santander, Cantabria, Spain. lucialavinalconero@gmail.com.; Clinical Trials Agency Valdecilla-IDIVAL, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain. lucialavinalconero@gmail.com., Fernández BJ; Management of primary health care centers, Area I, Area II, Area III and Area IV, Servicio Cantabro de Salud, C. Vargas 57, 39010, Santander, Cantabria, Spain., Marguello MG; Marqués de Valdecilla Research Institute (IDIVAL), s/n, Calle Cardenal Herrera Oria, 39012, Santander, Cantabria, Spain.; Department of Microbiology, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain., Caro JCL; Management of primary health care centers, Area I, Area II, Area III and Area IV, Servicio Cantabro de Salud, C. Vargas 57, 39010, Santander, Cantabria, Spain., Vallejo JD; Management of primary health care centers, Area I, Area II, Area III and Area IV, Servicio Cantabro de Salud, C. Vargas 57, 39010, Santander, Cantabria, Spain., Sampedro MF; Marqués de Valdecilla Research Institute (IDIVAL), s/n, Calle Cardenal Herrera Oria, 39012, Santander, Cantabria, Spain.; Department of Infectious Diseases, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain., Cacho PM; Marqués de Valdecilla Research Institute (IDIVAL), s/n, Calle Cardenal Herrera Oria, 39012, Santander, Cantabria, Spain.; Department of Community Health, Servicio Cantabro de Salud, C. Luis Vicente de Velasco 1, 39011, Santander, Cantabria, Spain., Espiga CR; Marqués de Valdecilla Research Institute (IDIVAL), s/n, Calle Cardenal Herrera Oria, 39012, Santander, Cantabria, Spain.; Emeritus Doctor, Department of Hematology, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain., Saiz MMG; Marqués de Valdecilla Research Institute (IDIVAL), s/n, Calle Cardenal Herrera Oria, 39012, Santander, Cantabria, Spain.; Clinical Trials Agency Valdecilla-IDIVAL, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain.; Department of Clinical Pharmacology, Marqués de Valdecilla University Hospital, Av. Valdecilla, 25, 39008, Santander, Cantabria, Spain.

Publikováno v: Trials [Trials] 2021 Sep 06; Vol. 22 (1), pp. 590. Date of Electronic Publication: 2021 Sep 06.